| systematic review | Q1504425 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050597684 |
| P356 | DOI | 10.1245/S10434-012-2438-8 |
| P932 | PMC publication ID | 3505531 |
| P698 | PubMed publication ID | 22766981 |
| P5875 | ResearchGate publication ID | 228330774 |
| P2093 | author name string | Colin H Wilson | |
| Alastair D Burt | |||
| Steven A White | |||
| Derek M Manas | |||
| Stuart M Robinson | |||
| P2860 | cites work | Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial | Q24647888 |
| Meta-analysis in clinical trials | Q27860779 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Irinotecan pharmacogenomics | Q28287024 | ||
| Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury | Q33389221 | ||
| The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery | Q33679698 | ||
| Ablative therapies for colorectal liver metastases: a systematic review | Q33937325 | ||
| Estimates of cancer incidence and mortality in Europe in 2008. | Q34095813 | ||
| Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). | Q34121577 | ||
| Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases | Q46129667 | ||
| Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection. | Q46493722 | ||
| Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases | Q46755766 | ||
| Effect of preoperative chemotherapy on liver resection for colorectal liver metastases | Q46832575 | ||
| Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy | Q46834872 | ||
| Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases | Q46931957 | ||
| Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. | Q51043928 | ||
| Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. | Q51804140 | ||
| A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. | Q52852810 | ||
| Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. | Q52853458 | ||
| Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases. | Q53595464 | ||
| Preoperative Chemotherapy and the Outcome of Liver Resection for Colorectal Metastases | Q57416461 | ||
| Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases | Q60675556 | ||
| Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy | Q71656886 | ||
| Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors | Q73857009 | ||
| Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal | Q73880478 | ||
| Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes | Q79303814 | ||
| Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases | Q79317416 | ||
| Preoperative systemic chemotherapy does not modify strategy of liver resection | Q79778301 | ||
| Epidemiology and management of liver metastases from colorectal cancer | Q79955500 | ||
| Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy | Q80215680 | ||
| Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome | Q80305396 | ||
| Chemotherapy in metastatic colorectal cancer | Q80375146 | ||
| The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study | Q81099536 | ||
| Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases | Q82053797 | ||
| Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases | Q82294696 | ||
| A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer | Q82758928 | ||
| Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection | Q83397664 | ||
| Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases | Q83889523 | ||
| Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy | Q85037030 | ||
| Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival | Q34551117 | ||
| Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study | Q34561850 | ||
| Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy. | Q36105021 | ||
| Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation | Q36165357 | ||
| Making unresectable hepatic colorectal metastases resectable--does it work? | Q36363334 | ||
| Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases | Q36464103 | ||
| Hepatic histology in obese patients undergoing bariatric surgery | Q36561289 | ||
| Safe liver resection following chemotherapy for colorectal metastases is a matter of timing | Q36610195 | ||
| Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases | Q36742173 | ||
| Modern multimodality approach to hepatic colorectal metastases: solutions and controversies | Q36833292 | ||
| Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases | Q36885794 | ||
| Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases | Q36926232 | ||
| Quantitative assessment of hepatic function and its relevance to the liver surgeon | Q37214685 | ||
| Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy | Q37287048 | ||
| Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases | Q37406393 | ||
| The role of preoperative chemotherapy in patients with resectable colorectal liver metastases | Q37530660 | ||
| Systemic chemotherapy and its implications for resection of colorectal liver metastasis | Q37644758 | ||
| Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. | Q37773864 | ||
| Sinusoidal Obstruction Syndrome | Q37807571 | ||
| Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology | Q37812185 | ||
| Chemotherapy before liver resection of colorectal metastases: friend or foe? | Q37951267 | ||
| Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization | Q38412939 | ||
| Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy | Q39879388 | ||
| Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases | Q40011784 | ||
| Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases | Q40108578 | ||
| Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. | Q40323520 | ||
| Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction | Q40347363 | ||
| Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? | Q42841253 | ||
| Influence of pre-surgical chemotherapy on liver parenchyma and post-surgical outcome of patients subjected to hepatectomy due to colorectal carcinoma metastases | Q42849355 | ||
| Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases | Q43010121 | ||
| Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis | Q43066523 | ||
| Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients | Q43125445 | ||
| Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases | Q43420356 | ||
| Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases | Q43519046 | ||
| Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Q44385945 | ||
| Assessment of hepatic steatosis by expert pathologists: the end of a gold standard | Q44661944 | ||
| Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. | Q44785271 | ||
| Factors influencing the natural history of colorectal liver metastases | Q44996217 | ||
| Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. | Q45033369 | ||
| Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? | Q45166892 | ||
| P433 | issue | 13 | |
| P921 | main subject | meta-analysis | Q815382 |
| chemotherapy | Q974135 | ||
| systematic review | Q1504425 | ||
| fatty liver disease | Q6058862 | ||
| liver neoplasm | Q18558073 | ||
| colorectal neoplasm | Q58833976 | ||
| antineoplastic combined chemotherapy protocols | Q66764603 | ||
| P304 | page(s) | 4287-4299 | |
| P577 | publication date | 2012-07-06 | |
| 2012-12-01 | |||
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis | |
| P478 | volume | 19 |
| Q37592234 | A pilot phase II study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer |
| Q42707141 | A simple transcriptomic signature able to predict drug-induced hepatic steatosis. |
| Q38230654 | Advances in understanding of colorectal liver metastasis and implications for the clinic |
| Q47097418 | Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: "a note of caution". |
| Q36243113 | Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis. |
| Q93226546 | Chemotherapy-induced liver injury in metastatic colorectal cancer: about 48 cases |
| Q34207776 | Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone? |
| Q64269104 | Current topics in liver surgery |
| Q89009287 | Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program |
| Q38524318 | Defining Post Hepatectomy Liver Insufficiency: Where do We stand? |
| Q41161751 | Effect of age on the development of chemotherapy-associated liver injury in colorectal cancer liver metastasis |
| Q48269857 | Genetic predisposition resulting in sinusoidal obstruction syndrome in a patient with resected sigmoid cancer on adjuvant oxaliplatin |
| Q37719073 | Hepatic Sinusoidal Obstruction Syndrome Induced by Non-transplant Chemotherapy for Non-Hodgkin Lymphoma |
| Q97534780 | Hepatic Steatosis After Neoadjuvant Chemotherapy for Pancreatic Cancer: Incidence and Implications for Outcomes After Pancreatoduodenectomy |
| Q91945266 | High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases |
| Q37350315 | Liver angulometry: a simple method to estimate liver volume and ratios |
| Q37067634 | Liver injury induced by anticancer chemotherapy and radiation therapy |
| Q90101857 | Liver microwave ablation: a systematic review of various FDA-approved systems |
| Q41641046 | Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience |
| Q38256165 | Liver-directed therapies in metastatic colorectal cancer |
| Q85993521 | Loss of chromosome 4 correlates with better long-term survival and lower relapse rate after R0-resection of colorectal liver metastases |
| Q90683623 | Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury |
| Q38887255 | MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD. |
| Q90581021 | Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases |
| Q33424109 | Oxaliplatin-based chemotherapy induces extravasated platelet aggregation in the liver |
| Q37011161 | Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. |
| Q38176084 | Pathology of the liver sinusoids |
| Q52604710 | Plants and Surgery: The Protective Effects of Thymoquinone on Hepatic Injury-A Systematic Review of In Vivo Studies. |
| Q26782806 | Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learned |
| Q58712022 | Post hepatectomy liver failure - A comprehensive review of current concepts and controversies |
| Q53302447 | Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. |
| Q38665331 | Preoperative Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Perioperative Liver-Related Complications Following Liver Resection for Colorectal Cancer Metastases |
| Q51193100 | Preoperative bevacizumab and surgery for colorectal liver metastases: a propensity score analysis. |
| Q34357769 | Preoperative chemotherapy for locally advanced resectable colon cancer - a new treatment paradigm in colon cancer? |
| Q58695102 | Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases |
| Q92292207 | Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed? |
| Q35761124 | Reductions in post-hepatectomy liver failure and related mortality after implementation of the LiMAx algorithm in preoperative work-up: a single-centre analysis of 1170 hepatectomies of one or more segments |
| Q90291316 | Safety Evaluation of Human Cord-Lining Epithelial Stem Cells Transplantation for Liver Regeneration in a Porcine Model |
| Q37711334 | Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy. |
| Q51827801 | Sinusoidal obstruction syndrome in the animal model: influence on liver surgery. |
| Q90735006 | Sinusoidal obstruction syndrome: A systematic review of etiologies, clinical symptoms, and magnetic resonance imaging features |
| Q38764790 | Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases. |
| Q36370523 | The association between preoperative chemotherapy and the prevalence of hepatic steatosis in hepatectomy for metastatic colorectal cancer. |
| Q97426299 | The liver matrisome - looking beyond collagens |
| Q55257627 | Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency. |
Search more.